BIG Impact portfolio firm AOI Biosciences secures patent for Toshiba co-developed drug discovery technology

• BIG Impact portfolio company AOI Biosciences secured a patent for drug-discovery technology co-developed with Toshiba.
• The patent covers an allosteric-site prediction method using Toshiba’s quantum-inspired optimization technology, SQBM+.
• AOI targets new approaches for proteins long viewed as difficult drug targets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIG Impact Inc published the original content used to generate this news brief on September 11, 2026, and is solely responsible for the information contained therein.